Children with disabilities <a href=" http://iibf.uludag.edu.tr/?purchase-robaxin.pdf ">buy methocarbamol uk</a> And Leerink Swann downgraded shares of Onyx Pharmaceuticals (ONXX) from outperform to market perform citing valuation. The stock is approaching the firm’s $140 price target, leaving less upside for investors. Shares of Onyx were lower today, falling 0.9%.